Cdkn2b | List of Frontiers open access articles

Original Research

Published on 24 Jul 2020

Deregulation of Polycomb Repressive Complex-2 in Mantle Cell Lymphoma Confers Growth Advantage by Epigenetic Suppression of cdkn2b

in Hematologic Malignancies

Christos Demosthenous
Shiv K. Gupta
Jing Sun
Yongsen Wang
Tammy P. Troska
Mamta Gupta

Frontiers in Oncology

doi 10.3389/fonc.2020.01226

5,065 views
8 citations

Original Research

Published on 29 Jan 2019

Long Non-coding RNA CDKN2B Antisense RNA 1 Gene Contributes to Paclitaxel Resistance in Endometrial Carcinoma

in Women's Cancer

Chao Shang
Cheng N. Ao
Chi C. Cheong
Lirong Meng

Frontiers in Oncology

doi 10.3389/fonc.2019.00027

4,812 views
23 citations

Original Research

Published on 31 Oct 2019

Aberrant Scinderin Expression Correlates With Liver Metastasis and Poor Prognosis in Colorectal Cancer

in Translational Pharmacology

Qi Lin
Jun Li
Dexiang Zhu
Zhengchuan Niu
Xiangou Pan
Pingping Xu
Meiling Ji
Ye Wei
Jianmin Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2019.01183

4,678 views
20 citations

Case Report

Published on 19 Feb 2025

Case report: The smallest 9p21.3 microdeletion involving CDKN2A but not CDKN2B causes multiple plexiform neurofibromas

in Cancer Genetics

Yuanyuan Zhang
Xiang Li
Haiming Gao
Chuang Qiu
Xiaoliang Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1437093

2,016 views
1 citation

Original Research

Published on 14 Jul 2022

Genomic Features of Organ-Specific Metastases in Lung Adenocarcinoma

in Cancer Genetics

Alei Feng
Yanjun Li
Guangxu Li
Yu Wang
Qiang Wen
Zhe Yang
Kaihua Tian
Hongying Lv
Lijie Guo
Shanshan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.908759

9,703 views
14 citations

Original Research

Published on 03 Mar 2023

The diagnostic significance of cerebrospinal fluid cytology and circulating tumor DNA in meningeal carcinomatosis

in Neurological Biomarkers

Wei-Ying Di
Ya-Nan Chen
Yun Cai
Qiang Geng
Yan-Li Tan
Chun-Hui Li
Ya-Nan Wang
Yan-Hong Shang
Chuan Fang
Shu-Jie Cheng

Frontiers in Neurology

doi 10.3389/fneur.2023.1076310

5,615 views
12 citations

Original Research

Published on 18 May 2022

Molecular Landscape and Prognostic Biomarker Analysis of Advanced Pancreatic Cancer and Predictors of Treatment Efficacy of AG Chemotherapy

in Cancer Genetics

Juan Du
Xin Qiu
Changchang Lu
Yahui Zhu
Weiwei Kong
Mian Xu
Xin Zhang
Min Tang
Jun Chen
Qi Li

Frontiers in Oncology

doi 10.3389/fonc.2022.844527

9,154 views
8 citations

Original Research

Published on 19 Jun 2023

Genomic landscape of clinically advanced KRAS wild-type pancreatic ductal adenocarcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Prashanth Ashok Kumar
Serenella Serinelli
Daniel J. Zaccarini
Richard Huang
Natalie Danziger
Tyler Janovitz
Alina Basnet
Abirami Sivapiragasam
Stephen Graziano
Jeffrey S. Ross

Frontiers in Oncology

doi 10.3389/fonc.2023.1169586

5,122 views
9 citations

Articles

Deregulation of Polycomb Repressive Complex-2 in Mantle Cell Lymphoma Confers Growth Advantage by Epigenetic Suppression of cdkn2b

Long Non-coding RNA CDKN2B Antisense RNA 1 Gene Contributes to Paclitaxel Resistance in Endometrial Carcinoma

Aberrant Scinderin Expression Correlates With Liver Metastasis and Poor Prognosis in Colorectal Cancer

Case report: The smallest 9p21.3 microdeletion involving CDKN2A but not CDKN2B causes multiple plexiform neurofibromas

Genomic Features of Organ-Specific Metastases in Lung Adenocarcinoma

The diagnostic significance of cerebrospinal fluid cytology and circulating tumor DNA in meningeal carcinomatosis

Molecular Landscape and Prognostic Biomarker Analysis of Advanced Pancreatic Cancer and Predictors of Treatment Efficacy of AG Chemotherapy

Genomic landscape of clinically advanced KRAS wild-type pancreatic ductal adenocarcinoma